학술논문
Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 Randomized Phase III Trial from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation
Document Type
Artikel
Author
Garderet, L; Iacobelli, S; Moreau, P; Dib, M; Lafon, I; Niederwieser, D; Masszi, T; Fontan, J; Michallet, M; Gratwohl, A; Milone, G; Doyen, C; Pegourie, B; Hajek, R; Casassus, P; Kolb, B; Chaleteix, C; Hertenstein, B; Onida, F; Ludwig, H; Ketterer, N; Koenecke, C; van Os, M; Mohty, M; Cakana, A; Gorin, NC; de Witte, T; Harousseau, JL; Morris, C; Gahrton, G
Source
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 30(20):2475-2482
Subject
Language
English
English
English
ISSN
1527-7755